Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4 - Wikidata - wikimedia - TriplyDB

Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4

Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4

http://www.wikidata.org/entity/Q40794919

about

Genetic and epigenetic regulation of intestinal fibrosis Recent developments in myofibroblast biology: paradigms for connective tissue remodeling Remodelling the extracellular matrix in development and disease The multifaceted functions of CXCL10 in cardiovascular disease Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis Gremlin-1 Overexpression in Mouse Lung Reduces Silica-Induced Lymphocyte Recruitment - A Link to Idiopathic Pulmonary Fibrosis through Negative Correlation with CXCL10 Chemokine Pulmonary fibrosis: patterns and perpetrators Indications for distinct pathogenic mechanisms of asbestos and silica through gene expression profiling of the response of lung epithelial cells Ubiquitin E3 ligase FIEL1 regulates fibrotic lung injury through SUMO-E3 ligase PIAS4 Syndecan-4 regulates early neutrophil migration and pulmonary inflammation in response to lipopolysaccharide.Baseline serum syndecan-4 predicts prognosis after the onset of acute exacerbation of idiopathic interstitial pneumonia Anti-asialo GM1 NK cell depleting antibody does not alter the development of bleomycin induced pulmonary fibrosis.Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis.CXCR3 Requirement for the Interleukin-13-Mediated Up-Regulation of Interleukin-13Rα2 in Pulmonary Fibroblasts Microbial Antigens Stimulate Metalloprotease-7 Secretion in Human B-Lymphocytes Using mTOR-Dependent and Independent Pathways.The impairment of ILK related angiogenesis involved in cardiac maladaptation after infarction.CXCR3-independent actions of the CXC chemokine CXCL10 in the infarcted myocardium and in isolated cardiac fibroblasts are mediated through proteoglycans Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation.Tumor necrosis factor-α- and interleukin-1β-dependent matrix metalloproteinase-3 expression in nucleus pulposus cells requires cooperative signaling via syndecan 4 and mitogen-activated protein kinase-NF-κB axis: implications in inflammatory disc di Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis.The role of interferon-γ inducible protein-10 in a mouse model of acute liver injury post induced pluripotent stem cells transplantation CXCR3 in T cell function.Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis.Heparan sulfate proteoglycans.Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44.Integrating mechanisms of pulmonary fibrosis Recruited exudative macrophages selectively produce CXCL10 after noninfectious lung injury MicroRNA-127 inhibits lung inflammation by targeting IgG Fcγ receptor I.Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury.Long-term exposure of chemokine CXCL10 causes bronchiolitis-like inflammation.Methylation-mediated BMPER expression in fibroblast activation in vitro and lung fibrosis in mice in vivo.Syndecan 4 Mediates Nrf2-dependent Expansion of Bronchiolar Progenitors That Protect Against Lung Inflammation.Smoking decreases the response of human lung macrophages to double-stranded RNA by reducing TLR3 expression.Heparan Sulfate in the Developing, Healthy, and Injured Lung.Transcription factor TBX4 regulates myofibroblast accumulation and lung fibrosis.Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling.International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.Up-regulation of heparan sulfate 6-O-sulfation in idiopathic pulmonary fibrosis Loss of Twist1 in the Mesenchymal Compartment Promotes Increased Fibrosis in Experimental Lung Injury by Enhanced Expression of CXCL12 The myofibroblast matrix: implications for tissue repair and fibrosis.

P2860

Q26740553-61FB64AB-D36C-486C-A399-6B26FCDE810D Q26863751-4F85058F-DFA5-4958-890D-4AC5320C4CEB Q26864798-08AB8400-13A2-42BE-B9A7-E0412C0B772F Q27010051-94E1D50C-49F2-44F8-84D6-1F0BEF18B372 Q27322182-885BD818-B46E-428F-AC4D-1EF9ADF7C44B Q27334805-3BBCF94B-0FDB-4160-9417-5BD01A67B46C Q27694249-0A4D100F-8123-497D-A7CF-AA8B2FFBF80D Q28392117-8AFAA991-D80D-46BF-B856-5BFEB384B9CD Q28395536-7315A9EA-B09B-4D21-A5F7-3E1320F5CD7B Q30524305-9C36D96A-1B52-4A31-B3AA-9911AF6A4D7F Q33632632-392D1464-7E93-4405-B284-5E74BAECCD7F Q33748545-862A5057-BC33-414C-A4FD-6237C601C6FB Q33756825-A6C9FC5A-FF84-4608-B83A-43B3B8A46255 Q33756881-A75D1A50-F55F-4C84-9F27-7A9EF70C7646 Q33818813-CF05322C-B7A4-49B6-9D14-C694C0D1E33F Q34031262-F6F1C40B-7E2F-4E45-A6EA-25E2A75E1BA3 Q34106221-9B48752C-A38B-4B3B-AA47-D86C30D5DE3C Q34160776-BB379B2F-0C0A-43E2-AD2B-70E244822EA1 Q34299937-303320CE-D1DC-40A3-8A13-FE61695B4FB3 Q34382756-A4F305C3-4AF7-47BA-850E-BA9C9BC85470 Q34507030-F445B328-60DC-47CB-9225-8ED455BCD461 Q34726782-9F30E424-C828-430E-BCE6-25751C155EE4 Q35005706-ABAAB539-7C48-45A9-AF14-DDC13E720A1F Q35059448-6A433F0B-2D62-4B20-B94E-3FF4269082DA Q35102315-54F15249-7989-4949-BEEB-FD1EA45C1830 Q35106452-57D2715A-6A33-4CB3-A2CF-89480035F0C2 Q35528061-89EFC122-D23D-4350-AFD1-E8312394BFF7 Q35783409-4BE6C857-18A4-4522-A7E0-BFE7A44B205B Q35967027-0EF85252-8433-4C86-A024-4007F61E3FD7 Q35987153-917E7C9F-A876-4159-9343-61326B63B1BE Q36128444-045CAB67-9229-4FBF-9069-E1C7B1E3394C Q36582808-D84CD1E3-CC90-4C7E-87AC-68C5BDA92FD5 Q36690891-98FC0797-6804-4A8C-9A98-A913F4515EF2 Q37088291-2E00E21C-68E5-4574-AC39-22EFD824354E Q37137920-5EBD76BF-89DE-4A94-8B04-71CEE76FB3B0 Q37304340-3F6F47A7-6EA0-423E-A201-6A7BBB5354EF Q37432097-4E6042AC-5D5F-46A3-BFCF-88EB8BD301B7 Q37596106-0578D49F-ADC5-4476-BEF6-9979BAF02C3A Q37681533-150C7ECE-53B8-48EE-B831-E2B4B3B608E4 Q37733670-5C38188C-5094-475D-84F8-602283002674

P2860

Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4

http://www.wikidata.org/entity/Q40794919

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Inhibition of pulmonary fibros ...... oglycan binding and syndecan-4

@en

type

label

Inhibition of pulmonary fibros ...... oglycan binding and syndecan-4

@en

prefLabel

Inhibition of pulmonary fibros ...... oglycan binding and syndecan-4

@en

P1433

Q40794919-385A1536-3042-41E2-B257-2F8512F953CB

P1476

Q40794919-23679C39-58E2-4C0B-BC81-3E329B51814E

P2093

Q40794919-0F544588-EBBB-4213-8AFB-2CC545FB390A

Q40794919-4057199D-2168-47F9-8379-C0CC1A664E58

Q40794919-6D39320E-A0D0-45D8-A4DA-4E621B99C67C

Q40794919-6E9EEF0C-1D84-4B9C-96E7-96179CA2C2F1

Q40794919-71B14F24-F849-4D49-AC04-4F3EF5B499DC

Q40794919-A6188161-FDD7-45EC-B250-8D6F82E5486B

Q40794919-AA8BF748-63A5-40A6-91B4-3A6FA9A929BD

Q40794919-BCF06068-5BDD-4459-82C7-6333C0E17AF0

Q40794919-C683373B-312D-4EC8-80AF-E163C27FF6D5

Q40794919-DA5AE46D-5A0C-4579-9402-1B2C88250AF5

P2860

Q40794919-02D921DC-94B2-4DD4-93A2-12AC2B6AA94D

Q40794919-06AC84E1-B05C-4543-B694-1A7A51287E85

Q40794919-0F0174F7-3D7F-43C3-AC42-FA5B7C02E324

Q40794919-11055006-4E44-43DA-856F-FBEB71B6A0CC

Q40794919-24873BE8-55AA-402A-8D4F-8230BDD8282E

Q40794919-2916A4B9-28B9-4F14-AB12-890CF00A81A7

Q40794919-2C92CD75-3C46-406D-A930-623CFCC1D7F2

Q40794919-356EF378-41B3-494F-B0D9-A46B38C4CEBA

Q40794919-388C3F7F-4F7C-474A-B9E2-78DADC07992C

Q40794919-3BAE6905-F3A9-4E79-800C-F476BC871A6E

P304

Q40794919-E8D895E0-BDD2-4E76-9398-EFF5C473F9E8

P31

Q40794919-7FB41B9A-408C-4121-BA55-8E21FCF6A506

P356

Q40794919-AD9696E6-F90C-4338-A1DB-2288C4D9E4BD

P407

Q40794919-5D6050E4-6A89-47C6-A1F0-274A1A4EABE2

P433

Q40794919-2125DCD0-F0A3-42C2-9A85-BD7BFD788908

P478

Q40794919-E445A9E3-6398-459E-AF03-43D17BC1BEBB

P50

Q40794919-3CC5BEC9-FAEA-40D9-8875-61DBA3FFDF60

Q40794919-A6FE96C1-C839-4111-B62B-42417BA42756

Q40794919-E4F07941-C03F-4575-87DF-221854A100BF

P577

Q40794919-D5A6D0F8-A9D1-4828-AF16-9C826D0C2256

P5875

Q40794919-03101436-800B-429B-AEAB-0448F317B5CD

P698

Q40794919-F0B70D6A-2EBD-4C82-804A-E7387A874EE8

P921

Q40794919-17153A9F-F3F2-47C7-809A-533981D6581B

P932

Q40794919-8DB8ED76-11EA-4DF7-B98B-0528316119C4

P356

P1433

Journal of Clinical Investigation

P1476

Inhibition of pulmonary fibros ...... oglycan binding and syndecan-4

@en

P2093

Andrew D Luster

http://www.w3.org/2001/XMLSchema#string

Andrew M Tager

http://www.w3.org/2001/XMLSchema#string

Eric B Meltzer

http://www.w3.org/2001/XMLSchema#string

Gabriele S Campanella

http://www.w3.org/2001/XMLSchema#string

Ningshan Liu

http://www.w3.org/2001/XMLSchema#string

Paul F Goetinck

http://www.w3.org/2001/XMLSchema#string

Paul W Noble

http://www.w3.org/2001/XMLSchema#string

Rishu Guo

http://www.w3.org/2001/XMLSchema#string

Shuang Yu

http://www.w3.org/2001/XMLSchema#string

Ting Xie

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of pulmonary fibrosis by chemokine receptor CXCR3

Matrix protein CCN1 is critical for prostate carcinoma cell proliferation and TRAIL-induced apoptosis

Requirement of the chemokine receptor CXCR3 for acute allograft rejection

Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4

Crystal structures of oligomeric forms of the IP-10/CXCL10 chemokine

Plasma levels of syndecan-4 (ryudocan) are elevated in patients with acute myocardial infarction

Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix

Enhanced migration of fibroblasts derived from lungs with fibrotic lesions.

CXC chemokines in angiogenesis.

Platelet-derived growth factor in idiopathic pulmonary fibrosis.

P304

2049-2057

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI38644

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

Robert J. Homer

P577

2010-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44613601

http://www.w3.org/2001/XMLSchema#string

P698

20484822

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

2877927

http://www.w3.org/2001/XMLSchema#string